Klimovsky Judith V 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jan 6, 2022
Insider Transaction Report
Form 4
Klimovsky Judith V.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-01-04+14,036→ 14,036 total - Exercise/Conversion
Common Stock
2022-01-04+566→ 14,602 total - Exercise/Conversion
Restricted Stock Units
2022-01-04−14,036→ 0 total→ Common Stock (14,036 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-04−566→ 0 total→ Common Stock (566 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of BLCM common stock.
- [F2]The RSUs vest in full upon the one year anniversary of the grant date on January 4, 2021.
- [F3]The RSUs granted on July 1, 2021 vest in full on January 4, 2022.